Questions and Answers on Informed Consent Elements, 21 CFR § 50.25(c): Guidance for Sponsors, Investigators, and Institutional Review Boards
Information
Type
Small Entity Compliance Guide
Regulated products
Biologics, Drugs, Medical Devices
Topics
Good Clinical Practice (GCP)
Published
February 1, 2012
Last updated
April 19, 2019
Description
A small entity compliance guide providing guidance on informed consent elements in clinical trials under 21 CFR § 50.25(c).
Tags
Organization
Country / Region
United States
License
Other (Public Domain)